Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Participants With Visual Acuity Impairment Associated With Atrophic Macular Degeneration

NCT00447954 is registered in ClinicalTrials.gov with Neurotech Pharmaceuticals as lead sponsor.

NCT NCT00447954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00447954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Implants of Encapsulated Human NTC-201 Cells Releasing Ciliary Neurotrophic Factor (CNTF), in Participants With Visual Acuity Impairment Associated With Atrophic Macular Degeneration
Lead sponsor
Neurotech Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
January 5, 2007
Completion date
May 11, 2009
Enrollment
53 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

nonexudative age-related macular degeneration, unspecified eye, intermediate dry stage